Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 2Completed 2Unknown 1Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 4Breast Neoplasms 3Osteoporosis 2Endometrial Neoplasms 2Hyperandrogenism 1Hot Flashes 1Endometrial Hyperplasia 1Coronary Disease 1Cardiovascular Diseases 1Brain Neoplasms 1

Interventions

Metformin 2drospirenone and ethinyl estradiol combination 1bicalutamide 1Ultrasonography 1Topiramate 1Spironolactone 1Progesterone 1Ovidrel 1Hematologic Tests 1Ethinyl Estradiol 1Dexamethasone 1Cyproterone acetate, ethinyl estradiol drug combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Hyperandrogenism × Progesterone × Clear all
NCT01428089 2023-11-02

Suppression of Daytime and Nighttime Luteinizing Hormone Frequency by Progesterone

University of Virginia

Phase 1 Unknown
40 enrolled

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡